b 213 750 (Niacin Extended-Release 750 mg)

Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia; niacin deficiency; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 213 750

Niacin Extended-Release

Imprint: b 213 750
Strength: 750 mg
Color: White
Shape: Capsule-shape
Availability: Rx and/or OTC
Drug Class: Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Teva Pharmaceuticals USA Inc.
National Drug Code (NDC): 00093-7393 (Discontinued)
Inactive Ingredients: povidone k90, stearic acid
Note: Inactive ingredients may vary.